Bydureon (by-DUR-ee-on), a new long-acting form of Byetta (exenatide) for type 2 diabetes

March 2012

You'll see Bydureon (by-DUR-ee-on), a new long-acting form of Byetta (exenatide) for type 2 diabetes.

Bydureon is injected just once a WEEK...compared to twice a day for Byetta or once a day for Victoza (liraglutide).

These glucagon-like peptide-1 (GLP-1) agonists are often added to oral meds to improve glycemic control and help patients lose weight.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cardiology new debate about which anticoagulant is best to prevent strokes in atrial fib patients
Cardiology more generic ARBs in 2012
Gastroenterology new warnings that PPIs (omeprazole, etc) might increase the risk of Clostridium difficile-associated diarrhea
Women's Health whether it's okay for women with migraine headaches to use combined oral contraceptives
Diabetes Bydureon (by-DUR-ee-on), a new long-acting form of Byetta (exenatide) for type 2 diabetes
Dermatology Picato (pih-KAY-toe) gel as a more convenient topical treatment for actinic keratosis
Dermatology Many OTCs for bruises and scars don't work
Infectious Diseases fewer options for treating pinworms now that mebendazole (Vermox) is discontinued
Antithrombotics whether it's okay to use aspirin to prevent thrombosis after hip or knee replacement surgery
Opioids how to handle tramadol drug interaction alerts
Dosage Forms if their meds contain animal products
Medicare Medicare, DEA, and others will crack down on patients abusing opioids and other controlled substances